clinical trial · NCT07845578
A Research Study Looking Into How a High Dose of s.c. Semaglutide Works With Emptying of the Stomach in People With Excess Body Weight
Novo Nordisk A/S·phase1·not yet recruiting·n = 60
ObesityOverweightSemaglutidePlacebo semaglutideParacetamol
brief summary
The purpose of the study is to determine the effect of semaglutide on gastric emptying in people with obesity. Participants will receive either semaglutide or placebo, and the treatment assigned will be decided by chance. Semaglutide is a medicine that doctors can already prescribe, while placebo contains no active medicine.
started
Sep 25, 2026
primary completion
Sep 11, 2027
completion
Sep 11, 2027
last updated
Sep 29, 2026
official title
An Investigation of the Effect of High Dose s.c. Semaglutide on Gastric Emptying in Participants With Obesity
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol